UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Histone Deacetylase Inhibitors: Design, Structure-Activity Relationships and Therapeutic Implications for Cancer
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Review
  • Authors:
    Marson CM
  • Publisher:
    BENTHAM SCIENCE PUBL LTD
  • Publication date:
    01/07/2009
  • Pagination:
    661, 692
  • Journal:
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
  • Volume:
    9
  • Issue:
    6
  • Status:
    Published
  • Print ISSN:
    1871-5206
  • Language:
    English
  • Keywords:
    Science & Technology, Life Sciences & Biomedicine, Oncology, Chemistry, Medicinal, Pharmacology & Pharmacy, Histone deacetylase (HDAC), HDAC isoform, histone deacetylase inhibitor, cancer therapy, hydroxamate, zinc-binding group, benzamide, cyclic peptide, SUBEROYLANILIDE HYDROXAMIC ACID, ADVANCED SOLID TUMORS, T-CELL LYMPHOMA, ACUTE PROMYELOCYTIC LEUKEMIA, ACTIVITY IN-VITRO, PHASE-II TRIAL, HDAC INHIBITOR, PROSTATE-CANCER, SPIRUCHOSTATIN-A, PHARMACODYNAMIC PD
  • Addresses:
    UCL
    Dept Chem
    Christopher Ingold Labs
    London
    England
    WC1H 0AJ
Abstract
No abstract found
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Author
Dept of Chemistry
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by